These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38172714)

  • 1. MYCT1 inhibits hematopoiesis in diffuse large B-cell lymphoma by suppressing RUNX1 transcription.
    Liang Y; Wei X; Yue PJ; Zhang HC; Li ZN; Wang XX; Sun YY; Fu WN
    Cell Mol Biol Lett; 2024 Jan; 29(1):5. PubMed ID: 38172714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA GAS5, as a ceRNA, inhibits the proliferation of diffuse large B‑cell lymphoma cells by regulating the miR‑18a‑5p/RUNX1 axis.
    Miao Y; Chen X; Qin M; Zhou W; Wang Y; Ji Y
    Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34698360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma.
    Yang M; Li W; Liu YY; Fu S; Qiu GB; Sun KL; Fu WN
    BMC Cancer; 2012 Jun; 12():219. PubMed ID: 22672838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
    Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
    J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress.
    Qu SY; Sun YY; Li YH; Xu ZM; Fu WN
    Cancer Med; 2017 Jun; 6(6):1389-1398. PubMed ID: 28485541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
    Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
    Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of miR-222-3p Promotes the Proliferation and Inhibits the Apoptosis of Diffuse Large B-Cell Lymphoma Cells via Suppressing PPP2R2A.
    Sun S; Wang H; Ji M
    Technol Cancer Res Treat; 2019; 18():1533033819892256. PubMed ID: 31829105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXD3 Up-regulating KDM5C Promotes Malignant Progression of Diffuse Large B-Cell Lymphoma by Decreasing p53 Expression.
    Cui Y; Lv C; Wen Y; Zhao D; Yang Y; Qiu H; Wang C
    Balkan Med J; 2022 Jan; 39(1):30-38. PubMed ID: 34928233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.
    Brady G; Whiteman HJ; Spender LC; Farrell PJ
    J Virol; 2009 Jul; 83(13):6909-16. PubMed ID: 19403666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
    Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
    Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1.
    Qadi AA; Taberlay PC; Phillips JL; Young A; West AC; Brettingham-Moore KH; Dickinson JL; Holloway AF
    J Cell Biochem; 2016 Jan; 117(1):49-58. PubMed ID: 26060100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Runt-related transcription factor 1 promotes apoptosis and inhibits neuroblastoma progression in vitro and in vivo.
    Hong M; He J; Li D; Chu Y; Pu J; Tong Q; Joshi HC; Tang S; Li S
    J Exp Clin Cancer Res; 2020 Mar; 39(1):52. PubMed ID: 32197643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-34a-5p suppresses the invasion and metastasis of liver cancer by targeting the transcription factor YY1 to mediate MYCT1 upregulation.
    Xu XP; Peng XQ; Yin XM; Liu Y; Shi ZY
    Acta Histochem; 2020 Sep; 122(6):151576. PubMed ID: 32778238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYCT1 represses apoptosis of laryngeal cancerous cells through the MAX/miR-181a/NPM1 pathway.
    Wang HT; Tong X; Zhang ZX; Sun YY; Yan W; Xu ZM; Fu WN
    FEBS J; 2019 Oct; 286(19):3892-3908. PubMed ID: 31152622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of RUNX1 inhibitor and gemcitabine mitigates chemo-resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress.
    She C; Wu C; Guo W; Xie Y; Li S; Liu W; Xu C; Li H; Cao P; Yang Y; Wang X; Chang A; Feng Y; Hao J
    J Exp Clin Cancer Res; 2023 Sep; 42(1):238. PubMed ID: 37697370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0027599 elevates RUNX1 expression via sponging miR-21-5p on gastric cancer progression.
    Han J; Yang Z; Zhao S; Zheng L; Tian Y; Lv Y
    Eur J Clin Invest; 2021 Nov; 51(11):e13592. PubMed ID: 34032284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
    Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
    Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
    Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
    PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RUNX1-activated upregulation of lncRNA RNCR3 promotes cell proliferation, invasion, and suppresses apoptosis in colorectal cancer via miR-1301-3p/AKT1 axis in vitro and in vivo.
    Xu G; Wang H; Yuan D; Yao J; Meng L; Li K; Zhang Y; Dang C; Zhu K
    Clin Transl Oncol; 2020 Oct; 22(10):1762-1777. PubMed ID: 32239427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX1 Regulates a Transcription Program That Affects the Dynamics of Cell Cycle Entry of Naive Resting B Cells.
    Thomsen I; Kunowska N; de Souza R; Moody AM; Crawford G; Wang YF; Khadayate S; Whilding C; Strid J; Karimi MM; Barr AR; Dillon N; Sabbattini P
    J Immunol; 2021 Dec; 207(12):2976-2991. PubMed ID: 34810221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.